Clinical experiment designed to assess clinical efficacy targeting N/A in human patients. Primary outcome: LPS levels in bacterial extracellular vesicles
This experiment involved the extraction of bacterial extracellular vesicles (bEVs) from fecal and blood samples of Alzheimer's disease patients and healthy controls. The researchers measured LPS levels within these bEVs to determine if AD patients showed elevated LPS-containing bEVs compared to healthy individuals. The study aimed to establish a clinical correlation between gut microbiota-derived vesicles and AD pathology by demonstrating increased LPS-carrying bEVs in patient plasma.
Extraction of bEVs from human feces and blood samples, followed by LPS level measurement
Elevated LPS-containing bEVs in AD patients compared to healthy controls
Statistically significant difference in LPS-containing bEVs between AD patients and controls
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.